ANRO
NYSE · Pharmaceuticals
Alto Neuroscience Inc
$24.71
+0.64 (+2.66%)
Open$23.89
Previous Close$24.07
Day High$24.72
Day Low$23.65
52W High$28.44
52W Low$2.12
Volume—
Avg Volume271.2K
Market Cap768.93M
P/E Ratio—
EPS$-2.21
SectorPharmaceuticals
Analyst Ratings
Strong Buy
16 analysts
Price Target
-10.3% upside
Current
$24.71
$24.71
Target
$22.17
$22.17
$14.63
$22.17 avg
$27.87
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 112.34M | 107.15M | 117.41M |
| Net Income | 25.21M | 21.35M | 24.46M |
| Profit Margin | 22.4% | 19.9% | 20.8% |
| EBITDA | 29.11M | 29.85M | 33.13M |
| Free Cash Flow | 25.43M | 19.85M | 18.41M |
| Rev Growth | +16.8% | +14.3% | +23.4% |
| Debt/Equity | 0.26 | 0.26 | 0.26 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $948.45 | -2.72% | 36.1 | 913.24B |
| JNJ | Johnson & Johnson | $221.32 | -0.53% | 26.1 | 548.94B |
| MRK | Merck & Co. Inc. | $111.38 | -0.82% | 31.3 | 279.42B |
| PFE | Pfizer Inc. | $25.68 | -3.02% | 19.3 | 150.09B |
| BMY | Bristol-Myers Squibb Co | $56.16 | -0.16% | 17.0 | 120.08B |
| ZTS | Zoetis Inc | $82.83 | -5.13% | 21.5 | 57.37B |